Affiliation:
1. Rostov State Medical University
2. Shpakovskaya Regional Hospital
3. Rostov-on-Don Southern District Medical Center — Federal Medical and Biological Agency
Abstract
Introduction. The aging process in men is accompanied by a progressive decrease in the level of serum testosterone (Tc). In addition to chronological aging, various factors contribute to the decline in testosterone levels. One of such factors contributing to the decrease in endogenous Tc and the development of secondary hypogonadism is the long-term use of testosterone preparations (TPs) used for non-medical purposes.Objective. To assess the nature of lower urinary tract symptoms following discontinuation of long-term non-medical use of testosterone preparations.Materials and methods. A clinical and statistical analysis of examination results in 31 men aged 22 – 46 years who received TPs for non-medical purposes while visiting gyms and subsequently turned to urologist with complaints of lower urinary tract symptoms (LUTS) was carried out. The study used the International Prostatic Symptom Score (IPSS) questionnaire, laboratory and instrumental examinations: general urine examination, general blood examination, prostate secretion microscopy, evaluation of serum total Tc, follicle-stimulating and luteinizing hormones, prolactin, estradiol, prostate ultrasound and bladder ultrasound, uroflowmetryResults. When assessing LUTS, the prevalence of irritative symptoms was noted. The level of serum total Tc in 13 (41.9%) men was in the range of 8 – 11 nmol/l, in 18 (58.1%) men it was below 8 nmol/l. In addition, most patients (77.4%) had areas of reduced blood flow in the prostate, and 67.7% had prostate fibrosis.Conclusion. Discontinuation of the use of long-term non-medical TPs can lead to the development of secondary hypogonadism and LUTS, which in most cases are irritative. In the treatment of these patients, an interdisciplinary rehabilitation program should be developed.
Publisher
Rostov State Medical University
Reference19 articles.
1. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D; European Male Aging Study Group. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93(7):2737-45. https://doi.org/10.1210/jc.2007-1972
2. Kogan MI, Vorobiev SV, Khripun IA, Belousov II, Ibishev KhS. Testosterone: from sexuality to metabolic control. Rostov-on-Don: Phoenix; 2017 (In Russ.)
3. Gusova Z.R., Dzantieva E.O. Importance of Visceral Obesity and Testosterone Deficiency in the formation of metabolic disorders in men. Urology Herald. 2019;7(3):14-22. (In Russ.) https://doi.org/10.21886/2308-6424-2019-7-3-14-22
4. Kuzmenko A.V., Kuzmenko V.V., Gyaurgiev T.A., Protsenko A.A., Shishonkova N.S. Erectile dysfunction because of psychological and somatic diseases in men of different age groups. Trends Dev Sci Edu. 2020;61(1) 44-47. (In Russ.) https://doi.org/10.18411/lj-05-2020-11
5. Mekhtiev TV, Mamedov MN. Treatment of age androgen deficiency with patients suffering from diabetes type 2. Resort medicine. 2015;2;122-6. (In Russ.) eLIBRARY ID: 24284561 EDN: ULKXBT